JMP Securities Downgrades Verastem (VSTM) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500, Dow futures dip as big banks' earnings roll in ahead of CPI data; IBM slides
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Cantor Fitzgerald Downgrades Verastem (VSTM) to Hold
September 28, 2015 5:10 PM EDTCantor Fitzgerald downgraded Verastem (NASDAQ: VSTM) from Buy to Hold with a price target of $4.00 (from $22.00).
Analyst Mara Goldstein commented, "With COMMAND stopping for futility, we are downgrading Verastem shares to HOLD from BUY. Though we believe the shares are likely over-penalized,... More
Jefferies Downgrades Verastem (VSTM) to Hold
September 28, 2015 4:43 PM EDTJefferies downgraded Verastem (NASDAQ: VSTM) from Buy to Hold with a price target of $2.00 (from $18.00).
For an analyst ratings summary and ratings history on Verastem click here. For more ratings news on Verastem click here.
Shares of Verastem closed at $5.67 yesterday.
... MoreRaymond James Downgrades Verastem (VSTM) to Outperform
September 28, 2015 3:06 PM EDTRaymond James downgraded Verastem (NASDAQ: VSTM) from Strong Buy to Outperform with a price target of $3.00 (from $12.00).
For an analyst ratings summary and ratings history on Verastem click here. For more ratings news on Verastem click here.
Shares of Verastem closed at $5.67 yesterday.
... MoreUBS Downgrades Verastem (VSTM) to Neutral
September 28, 2015 1:27 PM EDTUBS downgraded Verastem (NASDAQ: VSTM) from Buy to Neutral with a price target of $2.00.
For an analyst ratings summary and ratings history on Verastem click here. For more ratings news on Verastem click here.
Shares of Verastem closed at $5.67 yesterday.
... MoreMizuho Securities Downgrades Verastem (VSTM) to Neutral
September 28, 2015 1:25 PM EDTMizuho Securities downgraded Verastem (NASDAQ: VSTM) from Outperform to Neutral with a price target of $2.00 (from $21.00).
Analyst Eric Criscuolo commented, "We are downgrading VSTM from Buy to Neutral and lowering our PT from $21 to $2 following the failure of the COMMAND trial of... More
Roth Capital Downgrades Verastem (VSTM) to Neutral
September 28, 2015 9:37 AM EDTRoth Capital downgraded Verastem (NASDAQ: VSTM) from Buy to Neutral with a price target of $2.00 (from $23.00).
Analyst Joseph Pantginis commented, "There has been a major disappointment this morning as the pivotal COMMAND study using VS-6063 in mesothelioma was halted for futility following the... More
Verastem (VSTM) Ceases VS-6063 Phase 2 Enrollment in Mesothelioma Following DSMB Recommendation
September 28, 2015 7:01 AM EDTVerastem (NASDAQ: VSTM) announced that the Company has stopped enrollment in the Phase 2 registration-directed, double-blind, placebo-controlled study (COMMAND) of VS-6063 for patients with mesothelioma. The decision to stop enrollment for futility followed a Data Safety Monitoring Board (DSMB) review of a pre-planned interim analysis. The results of the analysis demonstrated that VS-6063 had a generally well... More
Verastem (VSTM) halted with news pending
September 28, 2015 6:56 AM EDTVerastem (NASDAQ: VSTM) trading halted with news pending.
... More